Lysophosphatidylcholine (LPC) triggers neuroinflammatory responses by activating the NLRP3 and NLRC4 inflammasomes in both microglial and astrocytic cells. This activation plays a crucial role in neurodegenerative diseases and demyelination, influencing the proliferation of these glial cells. Here, NLRP3 is linked to neurodegenerative disease.